In T2DM, periconceptional, noninsulin, second-line antidiabetes medications were not linked to major congenital malformations vs. insulin

Aoife M Egan

doi:10.7326/J24-0015

In T2DM, periconceptional, noninsulin, second-line antidiabetes medications were not linked to major congenital malformations vs. insulin

Ann Intern Med. 2024 Apr;177(4):JC47. doi: 10.7326/J24-0015. Epub 2024 Apr 2.

Author

Aoife M Egan¹

Affiliation

¹ Mayo Clinic, Rochester, Minnesota, USA (A.M.E.).

PMID: 38560907
DOI: 10.7326/J24-0015

Abstract

Cesta CE, Rotem R, Bateman BT, et al. Safety of GLP-1 receptor agonists and other second-line antidiabetics in early pregnancy. JAMA Intern Med. 2024;184:144-152. 38079178.

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Female
Humans
Hypoglycemic Agents / adverse effects
Insulin* / therapeutic use
Pregnancy

Substances

Insulin
Hypoglycemic Agents